(Q33889592)

29 July 2017

1 reference

title

A step ahead. Infant protection through maternal immunization (English)

1 reference

29 July 2017

0 references

Munoz FM

1

1 reference

29 July 2017

Englund JA

series ordinal

2

1 reference

29 July 2017

publication date

1 April 2000

1 reference

Pediatric Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

47

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

449-463

1 reference

Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Fetal-neonatal passive immunization against Hemophilus influenzae, type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunization to prevent group B streptococcal disease: victories and vexations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

The guinea pig as a model for the study of maternal immunization against respiratory syncytial virus infections in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Response of pregnant women and their infants to poliomyelitis vaccine; distribution of poliovirus antibody in pregnant women before and after vaccination; transfer, persistence, and induction of antibodies in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Respiratory syncytial virus-specific immunoglobulins in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal immunization against viral disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Haemophilus influenzae type b-specific antibody in infants after maternal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Serum Immunoglobulin Levels in Premature and Full-term Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Transplacental immunization of the human fetus to tetanus by immunization of the mother

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

A prospective study of influenza infections during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunity to and frequency of reinfection with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Risk factors for pertussis in young infants during an outbreak in Chicago in 1993

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

AN ATTEMPT TO INCREASE RESISTANCE TO PERTUSSIS IN NEWBORN INFANTS BY IMMUNIZING THEIR MOTHERS DURING PREGNANCY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal immunization for the prevention of bacterial infection in young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Influenza-associated morbidity and mortality in young and middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

The effectiveness of vaccination against influenza in healthy, working adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Maternal antibody and respiratory syncytial virus infection in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Congenital anomalies after oral poliovirus vaccination during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Neonatal sepsis caused by a new group B streptococcal serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

An epidemiologic approach to pneumococcal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Poliomyelitis in pregnancy: effect on fetus and newborn infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunization of Pregnant Women with Influenza A/New Jersey/76 Virus Vaccine: Reactogenicity and Immunogenicity in Mother and Infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970217-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70217-0

1 reference

29 July 2017

1 reference